- PharmaCielo receives game-changer award for the Latin America
Region
- Company celebrated for pioneering role in building Colombia's medical cannabis industry
TORONTO and RIONEGRO,
Colombia, Dec. 14, 2019 /CNW/ - PharmaCielo
Ltd. ("PharmaCielo" or the "Company")
(TSXV: PCLO, OTCQX: PCLOF), the Canadian parent of
Colombia's premier cultivator and
producer of medicinal-grade cannabis extracts, PharmaCielo Colombia
Holdings S.A.S., has been recognized with the prestigious MJ Biz
Daily Game-Changer Award for the Latin America Region. The
inaugural award was presented to the Company at a special gala,
part of the MJ Biz Conference in Las
Vegas, the world's largest cannabis conference and
tradeshow. The award program recognizes global leaders, both
companies and individuals, for their excellence and impact on the
hemp and cannabis industries.
"We are tremendously honoured to receive this award, but even
more thrilled that the panel of judges recognized PharmaCielo's
role and contribution in paving the way and building the medical
cannabis industry in Latin
America," said David
Attard, Chief Executive Officer, PharmaCielo Ltd. "Being
an industry trailblazer is a challenging task. It means that
whatever we do, every step of progress achieved, is a first for the
industry, with the rule book written as we go. Now that we have
laid the groundwork we are looking forward to a strong 2020 and
expanding our existing presence throughout Latin America which began with Mexico, and which in 2019 added a number of
others including both Uruguay and
Argentina. This achievement is
dedicated to PharmaCielo's employees who made this happen and who
continue to maintain PharmaCielo and Colombia's positions as top players on the
cannabis world stage."
About PharmaCielo
PharmaCielo Ltd. (TSXV: PCLO,
OTCQX: PCLOF) is a global company, headquartered in Canada, with a focus on ethical and
sustainable processing and supplying of all natural,
medicinal-grade cannabis oil extracts and related products to large
channel distributors. PharmaCielo's principal (and wholly owned)
subsidiary is PharmaCielo Colombia Holdings S.A.S., headquartered
at its nursery and propagation centre located in Rionegro,
Colombia.
The boards of directors and executive teams of both PharmaCielo
and PharmaCielo Colombia Holdings are comprised of a diversely
talented group of international business executives and specialists
with relevant and varied expertise. PharmaCielo recognized the
significant role that Colombia's
ideal location will play in building a sustainable business in the
medical cannabis industry, and the Company, together with its
directors and executives, is executing on a business plan focused
on supplying the international marketplace.
SOURCE PharmaCielo Ltd.